An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person posted before-and-after photos showing big changes in their body and face after starting a drug called Mounjaro. They shared the pictures without hiding their face and included the dosing schedule (titration) they followed. The post also mentions they began the drug one week after giving birth and were not breastfeeding. Mounjaro is the brand name for tirzepatide. It's a man-made version of hormones your gut makes after eating that help control appetite and blood sugar. In simple terms, it works on receptors in the body and brain that tell you to stop eating and help manage insulin and blood sugar levels. People are using it for type 2 diabetes and also for weight loss, sometimes with striking results. What’s shown here is an individual’s personal before-and-after photos plus the dosing steps they used. That’s an anecdote — one person’s experience — not a controlled study. We don’t know how long the photos span, what other changes (diet, exercise, other meds) happened, or whether photos were adjusted. Anecdotes can be compelling but don’t prove cause and effect. Larger, peer-reviewed studies of tirzepatide have shown notable average weight loss in groups of people, but a single social post can’t tell you how typical this result is. Why this matters to a regular person: drugs like tirzepatide are changing conversations about weight and health because some people see fast, visible changes. For someone struggling with obesity or type 2 diabetes, these medications can be valuable tools when used under medical supervision. Posts like this might make people curious, hopeful, or interested in trying the drug themselves — especially since the social media format shows dosing tips and real-life results. Caveats and risks: starting tirzepatide without a doctor is risky. Side effects commonly include nausea, diarrhea, constipation, and stomach pain. It can affect blood sugar and interact with other medications. The person’s note about starting one week after giving birth and not breastfeeding is important: these drugs are generally not recommended during breastfeeding because we don’t have good safety data. Also, photos and single reports don’t show long-term outcomes, maintenance of weight loss, or psychological effects. Regulatory approvals and recommended uses vary by country and condition, so medical guidance is essential. Bottom line: the post shows a dramatic personal result after starting Mounjaro, which is interesting but anecdotal — talk with a doctor to understand if a drug like tirzepatide is appropriate and safe for you.
Source: r/Mounjaro